The Androgen Deprivation Therapy Educational Programme
Registration - United Kingdom & Europe
To register, please complete the form below.
After completing the form below, you will receive a link to a short pre-registration form and confirmation of your registration.
If you are a healthcare professional and would like to observe an online ADT class, please contact us at: info.patientinformation@uroweb.org
The ADT class is hosted by the following institutions:
The Clatterbridge Cancer Centre, Wirral
Guy’s Hospital, London
Prostate Cancer UK, London
The Royal Marsden NHS Foundation Trust, Sutton Surrey
St. James Hospital, Dublin
University Hospitals Bristol and Weston NHS Foundation Trust
University Hospital Southampton
Please let us know if you receive, or have previously received, cancer treatment at one of the hospitals listed above and indicate which hospital. If you are not receiving treatment at any of these institutions, you can still register your interest and attend one of the classes.
The ADT class is hosted by the following institutions:
The Clatterbridge Cancer Centre, Wirral
Guy’s Cancer Centre, London
Friday, May 24th at 2:00 pm, in-person at Gordon Survivorship Hub
Friday, June 21st at 2:00 pm, in-person at Gordon Survivorship Hub
Friday, July 19th at 2:00 pm, in-person at Gordon Survivorship Hub
Prostate Cancer UK, London
Wednesday, April 24th, at 2:00 pm, in person at Prostate Cancer UK, London, Counting House
Thursday, May 16th, at 6:00 pm online via Zoom
Thursday, May 30th, at 3:30 pm online via Zoom
Monday, June 10th, at 6:00 pm online via Zoom
Tuesday, June 25th, at 6:00 pm online via Zoom
The Royal Marsden, Sutton
St. James Hospital, Dublin
Wednesday, May 8th, 2024, at 11:00 am online via Zoom
University Hospitals Bristol and Weston NHS Foundation Trust
Friday, April 19th at 2:30 pm online via Zoom
Friday, May 17th at 2:30 pm online via Zoom
Registration Form
Development and assessment of the current European edition of the book, as well as the European course facilitator training, were supported by an unrestricted educational grant from Astellas Europe and Bayer Healthcare Pharmaceuticals Inc, in collaboration with the European Association of Urology.
